Suppr超能文献

相似文献

1
Mouse models of acute and chronic hepacivirus infection.
Science. 2017 Jul 14;357(6347):204-208. doi: 10.1126/science.aal1962.
3
Vaccination to prevent T cell subversion can protect against persistent hepacivirus infection.
Nat Commun. 2019 Mar 7;10(1):1113. doi: 10.1038/s41467-019-09105-0.
4
T cell responses in hepatitis C virus infection: historical overview and goals for future research.
Antiviral Res. 2015 Feb;114:96-105. doi: 10.1016/j.antiviral.2014.11.009. Epub 2014 Nov 26.
5
Transmitted/Founder Viruses Rapidly Escape from CD8+ T Cell Responses in Acute Hepatitis C Virus Infection.
J Virol. 2015 May;89(10):5478-90. doi: 10.1128/JVI.03717-14. Epub 2015 Mar 4.
6
Cellular immune responses against hepatitis C virus.
Clin Infect Dis. 2005 Jul 1;41 Suppl 1:S25-31. doi: 10.1086/429492.
7
[Adaptive cell immune response against the hepatitis C virus infection].
Med Clin (Barc). 2007 Oct 6;129(12):469-76. doi: 10.1157/13111005.
9
Molecular Determinants of Mouse Adaptation of Rat Hepacivirus.
J Virol. 2023 Apr 27;97(4):e0181222. doi: 10.1128/jvi.01812-22. Epub 2023 Mar 27.

引用本文的文献

2
The PD-1/PD-L1 pathway and Epstein-Barr virus.
Eur J Med Res. 2025 Jun 18;30(1):486. doi: 10.1186/s40001-025-02694-1.
3
6
Mice Engrafted with Human Liver Cells.
Semin Liver Dis. 2024 Nov;44(4):405-415. doi: 10.1055/s-0044-1790601. Epub 2024 Sep 12.
7
Determinants of pegivirus persistence, cross-species infection, and adaptation in the laboratory mouse.
PLoS Pathog. 2024 Aug 28;20(8):e1012436. doi: 10.1371/journal.ppat.1012436. eCollection 2024 Aug.
9
An immunogenetic basis for lung cancer risk.
Science. 2024 Feb 23;383(6685):eadi3808. doi: 10.1126/science.adi3808.
10
New insights into the downregulation of cytochrome P450 2E1 via nuclear factor κB-dependent pathways in immune-mediated liver injury.
Heliyon. 2023 Nov 19;9(12):e22641. doi: 10.1016/j.heliyon.2023.e22641. eCollection 2023 Dec.

本文引用的文献

2
Immune Memory and Exhaustion: Clinically Relevant Lessons from the LCMV Model.
Adv Exp Med Biol. 2015;850:137-52. doi: 10.1007/978-3-319-15774-0_10.
3
Hepatitis C virus: why do we need a vaccine to prevent a curable persistent infection?
Curr Opin Immunol. 2015 Aug;35:137-43. doi: 10.1016/j.coi.2015.06.010. Epub 2015 Aug 1.
5
Overcoming T cell exhaustion in infection and cancer.
Trends Immunol. 2015 Apr;36(4):265-76. doi: 10.1016/j.it.2015.02.008. Epub 2015 Mar 18.
6
Surveying the global virome: identification and characterization of HCV-related animal hepaciviruses.
Antiviral Res. 2015 Mar;115:83-93. doi: 10.1016/j.antiviral.2014.12.014. Epub 2014 Dec 26.
7
The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development.
Front Immunol. 2014 Nov 10;5:550. doi: 10.3389/fimmu.2014.00550. eCollection 2014.
9
The ins and outs of hepatitis C virus entry and assembly.
Nat Rev Microbiol. 2013 Oct;11(10):688-700. doi: 10.1038/nrmicro3098. Epub 2013 Sep 10.
10
Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1).
Proc Natl Acad Sci U S A. 2013 Sep 10;110(37):15001-6. doi: 10.1073/pnas.1312772110. Epub 2013 Aug 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验